"The suit filed against Sanofi comes at the heels of Sanofi having received marketing approval for a Whole Cell Pertussis based Hexavalent vaccine by the Drugs Controller General (India)," Panacea Biotec said in a regulatory filing.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3eOrkyR
via IFTTT
0 comments:
Post a Comment